日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

A phase I study of gefitinib, capecitabine, and celecoxib in patients with advanced solid tumors

吉非替尼、卡培他滨和塞来昔布治疗晚期实体瘤患者的I期研究

期刊:Molecular Cancer Therapeutics
影响因子:5.5
doi:10.1158/1535-7163.MCT-08-0436
Lam, Elaine T; O'Bryant, Cindy L; Basche, Michele; Gustafson, Daniel L; Serkova, Natalie; Baron, Anna; Holden, Scott N; Dancey, Janet; Eckhardt, S Gail; Gore, Lia
发表日期：2008
文献求助 收藏

A phase I safety, pharmacological, and biological study of the farnesyl protein transferase inhibitor, lonafarnib (SCH 663366), in combination with cisplatin and gemcitabine in patients with advanced solid tumors

一项针对晚期实体瘤患者的法尼基蛋白转移酶抑制剂lonafarnib（SCH 663366）联合顺铂和吉西他滨的I期安全性、药理学和生物学研究

期刊:Cancer Chemotherapy and Pharmacology
影响因子:2.3
doi:10.1007/s00280-007-0646-x
Chow, Laura Q M; Eckhardt, S Gail; O'Bryant, Cindy L; Schultz, Mary Kay; Morrow, Mark; Grolnic, Stacy; Basche, Michele; Gore, Lia
发表日期：2008
文献求助 收藏

A phase I pharmacological and biological study of PI-88 and docetaxel in patients with advanced malignancies.

PI-88 和多西他赛治疗晚期恶性肿瘤患者的 I 期药理学和生物学研究

期刊:Cancer Chemotherapy and Pharmacology
影响因子:2.3
doi:10.1007/s00280-008-0712-z
Chow Laura Q M, Gustafson Daniel L, O'Bryant Cindy L, Gore Lia, Basche Michele, Holden Scott N, Morrow Mark C, Grolnic Stacy, Creese Brian R, Roberts Kaye L, Davis Kat, Addison Russell, Eckhardt S Gail
肿瘤
肿瘤免疫
发表日期：2008
文献求助 收藏

Barriers to enrollment of elderly adults in early-phase cancer clinical trials

老年人参与早期癌症临床试验的障碍

期刊:Journal of Oncology Practice
影响因子:
doi:10.1200/JOP.0842001
Basche, Michele; Barón, Anna E; Eckhardt, S Gail; Balducci, Lodovico; Persky, Martha; Levin, Adrah; Jackson, Nathaniel; Zeng, Chan; Vranas, Pamela; Steiner, John F
肿瘤
肿瘤免疫
发表日期：2008
文献求助 收藏